Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2004 2
2005 2
2006 3
2007 1
2009 1
2010 3
2011 8
2012 3
2013 7
2014 5
2015 7
2016 3
2017 6
2018 3
2019 5
2020 7
2021 6
2022 12
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
Kearney K, Brown K, Celermajer DS, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Keating D, Keogh A, Kotlyar E, Lavender M, McWilliams T, Williams T, Whitford H, Weintraub R, Wrobel J, Ellender C, Anderson J, Lau EM; PHSANZ Registry. Kearney K, et al. Among authors: kotlyar e. Chest. 2024 Apr;165(4):967-977. doi: 10.1016/j.chest.2023.10.037. Epub 2023 Nov 10. Chest. 2024. PMID: 37951349
Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation.
Anthony C, Imran M, Pouliopoulos J, Emmanuel S, Iliff J, Liu Z, Moffat K, Ru Qiu M, McLean CA, Stehning C, Puntmann V, Vassiliou V, Ismail TF, Gulati A, Prasad S, Graham RM, McCrohon J, Holloway C, Kotlyar E, Muthiah K, Keogh AM, Hayward CS, Macdonald PS, Jabbour A. Anthony C, et al. Among authors: kotlyar e. Circulation. 2022 Jun 21;145(25):1811-1824. doi: 10.1161/CIRCULATIONAHA.121.057006. Epub 2022 May 27. Circulation. 2022. PMID: 35621277 Clinical Trial.
Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis.
Brennan X, Withers B, Jabbour A, Milliken S, Kotlyar E, Fay K, Ma D, Muthiah K, Hamad N, Dodds A, Bart N, Keogh A, Hayward C, Macdonald P, Moore J. Brennan X, et al. Among authors: kotlyar e. Intern Med J. 2022 Oct;52(10):1826-1830. doi: 10.1111/imj.15926. Intern Med J. 2022. PMID: 36266066 Free PMC article.
91 results